The abstract is read at the publisher; the summary is JClub's.
In 239 biopsy-proven lupus nephritis patients, baseline low-grade proteinuria (UPro <1 g/24 h) does not predict a lower risk of 30% or 40% eGFR decline over 156 weeks.
- Why it matters: Clinicians need to know whether milder baseline proteinuria identifies lupus nephritis patients with better prognosis or treatment response, to guide monitoring and therapy intensity.
- What they did: Patients were stratified by baseline 24-h urine protein (<1 g/24 h vs ≥1 g/24 h) and onset status (incident vs relapsing), with renal responses assessed at weeks 26 and 52 and eGFR decline modeled to 156 weeks using Cox and Kaplan-Meier analyses.
- The result: Both proteinuria groups showed similar overall renal response rates at weeks 26 and 52, and low-grade proteinuria had equivalent risk probabilities for eGFR decline; glomerulosclerosis independently predicted long-term deterioration in relapsing but not incident LN.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.